Eflapegrastim
Plonmarlimab
Otilimab
Gimsilumab
Axatilimab
Anumigilimab
Balugrastim
Cabiralizumab
Namilumab
Lacnotuzumab
Anti-Mouse GM-CSF Antibody (MP1-22E9)
Mavrilimumab
Trabikibart
c-Fms-IN-2
CSF1R-IN-22
CSF1R-IN-20
c-Fms-IN-15
CSF1R-IN-18
CSF1R-IN-25
PXB17